Since our immunostaining data indicated that p16 was localized predominantly within the cytoplasm in HCC tissues, we ascertained the cellular localization of p16 in the HCC cell lines used in our prior experiments. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.